The project Protons contra cancer (PROCCA) was selected as one out of eight new convergence environments that receive funding from UiO: Life Science this year. The convergence environment consists of interdisciplinary research groups that address major challenges within health and environment. The PROCCA consortium intends to create an excellent platform for collaborative efforts in proton therapy research in Oslo, and consists of research groups from several departments at UiO and OUS.
The consortium is headed by Eirik Malinen, Department of Physics, UiO, and Department of Medical Physics, OUS. At Institute for Cancer Research, Åslaug Helland, Department of Genetics, is one of the principal investigators, and Randi Syljuåsen and Heidi Lyng at Department of Radiation Biology are collaborators.